Colon cancers with microsatellite instability are usually p53-normal and have a defective CHFR mitotic checkpoint, and are therefore an interesting target for AK301 (and similarly acting agents), particularly if they also have an APC mutation. The gene discussed is APC; the disease is colonic neoplasm.